A股异动 | 华大智造(688114.SH)涨超8% 虚拟细胞走向工程化落地公司联手百图生科绑定AI制药下一代基础设施

智通财经14:02

智通财经APP获悉，华大智造(688114.SH)午后涨超8%，截至发稿，涨7.36%，报58.37元，成交额3.81亿元。

消息面上，9月11日，全栈生命科学工具全球提供商华大智造与生命科学基础大模型全球领跑者百图生科达成战略合作：双方将面向具体客户和研发场景，共建专属细胞大模型，并以此为底座，开发面向虚拟细胞、虚拟扰动的专属高质量数据产出基础设施。AI4S基座龙头与AI4S头部大模型的联手，落点是行业最稀缺的高质量数据产能。

需要关注的是，高质量实验数据是大模型最稀缺的“燃料”，而规模化产出这类数据的能力，正是华大智造沉淀多年的核心资产。对华大智造而言，此次合作意味着其全栈工具链再一次成为前沿研发的“基座”——跨组学仪器与实验体系不仅完成一次性实验验证，更通过持续验证，规模化沉淀高质量真实世界数据，反哺模型迭代。未来，双方还将推动上述联合能力的标准化和产品化，探索“设备+模型+智能体”一体化产品及AI CRO等合作模式。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2667588066?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-14 14:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2667588066","market":"us","top_or_hot":-1,"title":"A股异动 | 华大智造(688114.SH)涨超8% 虚拟细胞走向工程化落地 公司联手百图生科绑定AI制药下一代基础设施","media":"智通财经","content":"<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/688114\">华大智造</a>(688114.SH)午后涨超8%，截至发稿，涨7.36%，报58.37元，成交额3.81亿元。</p><p>消息面上，9月11日，全栈生命科学工具全球提供商华大智造与生命科学基础大模型全球领跑者百图生科达成战略合作：双方将面向具体客户和研发场景，共建专属细胞大模型，并以此为底座，开发面向虚拟细胞、虚拟扰动的专属高质量数据产出基础设施。AI4S基座龙头与AI4S头部大模型的联手，落点是行业最稀缺的高质量数据产能。</p><p>需要关注的是，高质量实验数据是大模型最稀缺的“燃料”，而规模化产出这类数据的能力，正是华大智造沉淀多年的核心资产。对华大智造而言，此次合作意味着其全栈工具链再一次成为前沿研发的“基座”——跨组学仪器与实验体系不仅完成一次性实验验证，更通过持续验证，规模化沉淀高质量真实世界数据，反哺模型迭代。未来，双方还将推动上述联合能力的标准化和产品化，探索“设备+模型+智能体”一体化产品及AI CRO等合作模式。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A股异动 | 华大智造(688114.SH)涨超8% 虚拟细胞走向工程化落地 公司联手百图生科绑定AI制药下一代基础设施</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA股异动 | 华大智造(688114.SH)涨超8% 虚拟细胞走向工程化落地 公司联手百图生科绑定AI制药下一代基础设施\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP获悉，<a href=\"https://laohu8.com/S/688114\">华大智造</a>(688114.SH)午后涨超8%，截至发稿，涨7.36%，报58.37元，成交额3.81亿元。</p><p>消息面上，9月11日，全栈生命科学工具全球提供商华大智造与生命科学基础大模型全球领跑者百图生科达成战略合作：双方将面向具体客户和研发场景，共建专属细胞大模型，并以此为底座，开发面向虚拟细胞、虚拟扰动的专属高质量数据产出基础设施。AI4S基座龙头与AI4S头部大模型的联手，落点是行业最稀缺的高质量数据产能。</p><p>需要关注的是，高质量实验数据是大模型最稀缺的“燃料”，而规模化产出这类数据的能力，正是华大智造沉淀多年的核心资产。对华大智造而言，此次合作意味着其全栈工具链再一次成为前沿研发的“基座”——跨组学仪器与实验体系不仅完成一次性实验验证，更通过持续验证，规模化沉淀高质量真实世界数据，反哺模型迭代。未来，双方还将推动上述联合能力的标准化和产品化，探索“设备+模型+智能体”一体化产品及AI CRO等合作模式。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1495533.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02846","symbol_name":"安硕沪深三百","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1495533.html","article_id":"2667588066","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2667588066","pubTimestamp":1789365758,"columns":[{"name":"A股","id":33,"label_key":"policyRegulatory"}],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，华大智造午后涨超8%，截至发稿，涨7.36%，报58.37元，成交额3.81亿元。消息面上，9月11日，全栈生命科学工具全球提供商华大智造与生命科学基础大模型全球领跑者百图生科达成战略合作：双方将面向具体客户和研发场景，共建专属细胞大模型，并以此为底座，开发面向虚拟细胞、虚拟扰动的专属高质量数据产出基础设施。AI4S基座龙头与AI4S头部大模型的联手，落点是行业最稀缺的高质量数据产能。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"82846":"安硕沪深三百—R","83130":"恒生沪深三百-R","83188":"华夏沪深三百—R","159982":"中证500","399300":"沪深300","688114":"华大智造","02846":"安硕沪深三百","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","03130":"恒生沪深三百","BK1147":"投资银行业与经纪业","BK1574":"生物医药B类股","ARTY":"ISHARES FUTURE AI & TECH ETF","01477":"欧康维视生物-B","VTHR":"Vanguard Russell 3000 ETF","02827":"标智沪深300","AGIX":"通用人工智能 ETF-AGIX","BK0251":"专用设备","07233":"南方两倍做多沪深300","BK1191":"制药","QTOC":"Innovator Growth Accelerated Plus ETF - October","AIPO":"Defiance AI and Power Infrastructure ETF","03188":"华夏沪深三百"},"translate_title":"A-shares in Focus | BGI Genomics (688114.SH) Surges Over 8% as Virtual Cells Move Towards Engineering Implementation; Company Partners with Baitu Biotechnology to Bind Next-Generation AI Pharmaceutical Infrastructure","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"82846":0.6,"83130":0.6,"83188":0.6,"159982":1.5,"399300":1.5,"688114":1.5,"03188":1.5,"ARTY":1.5,"03130":0.6,"QTOC":1.5,"AIPO":1.5,"07233":0.6,"01477":1.5,"02827":0.6,"AGIX":1.5,"02846":0.6,"CHAT":1.5,"VTHR":1.5},"content_text":"智通财经APP获悉，华大智造(688114.SH)午后涨超8%，截至发稿，涨7.36%，报58.37元，成交额3.81亿元。消息面上，9月11日，全栈生命科学工具全球提供商华大智造与生命科学基础大模型全球领跑者百图生科达成战略合作：双方将面向具体客户和研发场景，共建专属细胞大模型，并以此为底座，开发面向虚拟细胞、虚拟扰动的专属高质量数据产出基础设施。AI4S基座龙头与AI4S头部大模型的联手，落点是行业最稀缺的高质量数据产能。需要关注的是，高质量实验数据是大模型最稀缺的“燃料”，而规模化产出这类数据的能力，正是华大智造沉淀多年的核心资产。对华大智造而言，此次合作意味着其全栈工具链再一次成为前沿研发的“基座”——跨组学仪器与实验体系不仅完成一次性实验验证，更通过持续验证，规模化沉淀高质量真实世界数据，反哺模型迭代。未来，双方还将推动上述联合能力的标准化和产品化，探索“设备+模型+智能体”一体化产品及AI CRO等合作模式。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2667588066","isCrawlerRequest":true}